My Mom has been started on Keytruda as secondline treatment for her SCLC, initially diagnosed as limited stage. It has now progressed to other sites within her lung only. Her doctor has not tested to see if her tumor expresses PDL1. Wonder if anyone has any thoughts regarding this? Anyone else out there know of any similar cases? Thanks in advance.
You must log in to use this feature, please click here to login.